
Penumbra PEN
$ 336.57
0.09%
Annual report 2025
added 02-25-2026
Country |
|
IPO year |
2015 |
Industry |
Medical devices |
Stock Exchange |
NYSESPB |
Shares |
38.9 M |
Market Cap[1] |
$ 13.1 B |
EBITDA (LTM) |
$ 171 M |
P/E (LTM) |
81.62 |
P/S (LTM) |
9.92 |
EPS (LTM) |
4.12 |
Other stocks of industry "Medical devices"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
AxoGen
AXGN
|
$ 33.28 | 0.02 % | $ 1.53 B | Nasdaq Capital Market,SPB | ||
|
EDAP TMS S.A.
EDAP
|
$ 3.87 | 4.18 % | $ 145 M | Nasdaq Global Market | ||
|
GenMark Diagnostics, Inc.
GNMK
|
- | - | $ 1.77 B | Nasdaq Global Select Market | ||
|
Axonics Modulation Technologies
AXNX
|
- | - | $ 3.31 B | Nasdaq Global Select Market,SPB | ||
|
Lianluo Smart Limited
LLIT
|
- | 24.59 % | $ 44.8 M | Nasdaq Global Select Market | ||
|
Helius Medical Technologies
HSDT
|
$ 2.08 | -3.7 % | $ 1.26 M | Nasdaq Capital Market | ||
|
Aziyo Biologics
AZYO
|
- | 1.37 % | $ 20.5 M | Nasdaq Global Market | ||
|
Acutus Medical
AFIB
|
- | -26.83 % | $ 2.62 M | Nasdaq Global Select Market | ||
|
BioSig Technologies
BSGM
|
- | 37.08 % | $ 85.7 M | Nasdaq Global Select Market | ||
|
IRadimed Corporation
IRMD
|
$ 100.73 | -1.04 % | $ 1.28 B | Nasdaq Global Select Market | ||
|
Allied Healthcare Products
AHPI
|
- | 3.58 % | $ 2.21 M | Nasdaq Capital Market | ||
|
Obalon Therapeutics, Inc.
OBLN
|
- | -5.86 % | $ 30.6 M | Nasdaq Capital Market | ||
|
LENSAR
LNSR
|
$ 5.54 | -0.72 % | $ 63.8 M | Nasdaq Capital Market | ||
|
Medtronic PLC
MDT
|
$ 88.01 | 0.14 % | $ 113 B | NYSE,SPB | ||
|
Conformis
CFMS
|
- | - | $ 16.4 M | Nasdaq Capital Market | ||
|
Delcath Systems
DCTH
|
$ 9.22 | 0.16 % | $ 330 M | Nasdaq Capital Market | ||
|
Dynatronics Corporation
DYNT
|
- | 14.99 % | $ 929 K | Nasdaq Capital Market | ||
|
Cardiovascular Systems
CSII
|
- | 0.15 % | $ 844 M | Nasdaq Global Select Market,SPB | ||
|
Second Sight Medical Products
EYES
|
- | -0.97 % | $ 54.4 M | Nasdaq Capital Market | ||
|
Apollo Endosurgery
APEN
|
- | - | $ 475 M | Nasdaq Global Market | ||
|
Orthofix Medical
OFIX
|
$ 11.96 | 0.25 % | $ 474 M | Nasdaq Global Select Market,SPB | ||
|
Outset Medical
OM
|
$ 3.65 | 3.51 % | $ 55.5 K | Nasdaq Global Select Market | ||
|
Avinger
AVGR
|
- | -20.74 % | $ 369 K | Nasdaq Capital Market | ||
|
CryoLife, Inc.
CRY
|
- | -4.14 % | $ 702 M | NYSE,SPB | ||
|
CHF Solutions, Inc.
CHFS
|
- | 1.15 % | $ 34.5 M | Nasdaq Capital Market | ||
|
Insulet Corporation
PODD
|
$ 220.03 | 1.87 % | $ 15.5 B | Nasdaq Global Select Market,SPB | ||
|
Profound Medical Corp.
PROF
|
$ 5.95 | 2.23 % | $ 180 M | Nasdaq Global Select Market | ||
|
CONMED Corporation
CNMD
|
$ 36.97 | -0.3 % | $ 1.15 B | NYSE,SPB | ||
|
Quanterix Corporation
QTRX
|
$ 4.08 | 2.95 % | $ 174 M | Nasdaq Global Select Market,SPB | ||
|
Soliton, Inc.
SOLY
|
- | -1.42 % | $ 435 M | Nasdaq Global Select Market | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
- | -1.98 % | $ 98.3 M | Nasdaq Capital Market | ||
|
Itamar Medical Ltd.
ITMR
|
- | 0.03 % | $ 1.58 B | Nasdaq Global Select Market | ||
|
Electromed
ELMD
|
$ 24.72 | 0.24 % | $ 209 M | NYSE American | ||
|
Misonix, Inc.
MSON
|
- | - | $ 462 M | Nasdaq Global Select Market | ||
|
Neovasc
NVCN
|
- | - | $ 111 M | Nasdaq Capital Market | ||
|
Integra LifeSciences Holdings Corporation
IART
|
$ 9.84 | 3.04 % | $ 758 M | Nasdaq Global Select Market,SPB | ||
|
Sintx Technologies
SINT
|
$ 2.62 | 2.34 % | $ 7.27 M | Nasdaq Capital Market | ||
|
Intersect ENT, Inc.
XENT
|
- | - | $ 955 M | Nasdaq Global Market | ||
|
IRIDEX Corporation
IRIX
|
$ 1.34 | 1.13 % | $ 21.6 M | Nasdaq Global Select Market | ||
|
Cytosorbents Corporation
CTSO
|
$ 0.57 | -15.11 % | $ 31 M | Nasdaq Capital Market | ||
|
Aethlon Medical
AEMD
|
$ 2.36 | 1.72 % | $ 3.68 M | Nasdaq Capital Market | ||
|
Smith & Nephew plc
SNN
|
$ 32.52 | 0.22 % | $ 23.8 B | NYSE | ||
|
BIOLASE
BIOL
|
- | -13.19 % | $ 166 K | Nasdaq Capital Market | ||
|
Sensus Healthcare
SRTS
|
$ 4.1 | -2.84 % | $ 66.9 M | Nasdaq Capital Market | ||
|
LivaNova PLC
LIVN
|
$ 64.29 | 1.56 % | $ 3.51 B | Nasdaq Global Select Market | ||
|
InspireMD
NSPR
|
$ 1.77 | - | $ 114 M | NYSE American | ||
|
Stryker Corporation
SYK
|
$ 329.43 | 0.54 % | $ 126 B | NYSE,SPB | ||
|
AdaptHealth Corp.
AHCO
|
$ 11.5 | 0.97 % | $ 1.55 B | Nasdaq Capital Market | ||
|
MiMedx Group
MDXG
|
$ 4.09 | -0.37 % | $ 604 M | Nasdaq Global Select Market |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.